Data / Drug companies / Calcium gluconate
Calcium gluconate: 14 companies and 38 products in the FDA NDC directory
Calcium gluconate is listed in the FDA National Drug Code Directory by 14 companies, with 38 products in commercial distribution. 22 of the products (57.9%) are marketed under an abbreviated new drug application (ANDA), the generic route. The most common dosage forms are injection, solution, and the newest product started marketing on May 13, 2026.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Companies listing it
- 14
- Products
- 38
- Generic (ANDA) products
- 22 (57.9%)
- Application numbers
- 8
- Routes
- Intravenous
- openFDA record search
- api.fda.gov
Companies that list calcium gluconate
Ranked by number of products. Finished drugs in commercial distribution.
| Company | Products | Main dosage forms | Main marketing category | Newest product started |
|---|---|---|---|---|
| Amneal Pharmaceuticals Private Limited | 8 | injection, solution | Generic drugs (ANDA) | April 13, 2026 |
| WG Critical Care, LLC | 6 | injection, solution | New drug applications (NDA) | July 13, 2021 |
| Caplin Steriles Limited | 3 | injection, solution | Generic drugs (ANDA) | May 13, 2026 |
| Fresenius Kabi USA, LLC | 3 | injection, solution | New drug applications (NDA) | June 17, 2021 |
| Glenmark Pharmaceuticals Inc., USA | 3 | injection, solution | Generic drugs (ANDA) | May 4, 2026 |
| Hikma Pharmaceuticals USA Inc. | 3 | injection, solution | Generic drugs (ANDA) | June 30, 2024 |
| HF Acquisition Co LLC, DBA HealthFirst | 2 | injection, solution | New drug applications (NDA) | December 21, 2018 |
| Henry Schein, Inc. | 2 | injection, solution | New drug applications (NDA) | December 23, 2025 |
| Remedyrepack Inc. | 2 | injection, solution | Generic drugs (ANDA) | June 11, 2025 |
| Somerset Therapeutics, LLC | 2 | injection, solution | Generic drugs (ANDA) | October 20, 2023 |
| B. Braun Medical Inc. | 1 | injection, solution | Generic drugs (ANDA) | November 2, 2023 |
| Fresenius Kabi USA, LLC | 1 | injection, solution | New drug applications (NDA) | June 15, 2017 |
| Medical Purchasing Solutions, LLC | 1 | injection, solution | New drug applications (NDA) | June 15, 2017 |
| ProPharma Distribution | 1 | injection, solution | New drug applications (NDA) | June 15, 2017 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Injection, solution | 38 | 100% |
Marketing categories
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 22 | 57.9% |
| New drug applications (NDA) | 16 | 42.1% |
Pharmacologic classes
| Class | Products |
|---|---|
| Blood Coagulation Factor | 38 |
| Phosphate Binder | 37 |
Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.